Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 754 results for "sandoz inc"


Mississippi SC upholds a multi-million dollar verdict in opposition to Sandoz, Inc. [National Iraqi News Agency (Iraq)]

The Mississippi Supreme Court affirmed a $30 million bench verdict in Sandoz v. State of Mississippi. Here is Court's the opinion and here is my 2011 post mentioning the verdict. This was a state A.G. case that charged Sandoz with inflating ...
 Pharmacy Choice3 weeks ago Mississippi Supreme Court upholds a multi-million dollar ruling against Sandoz, Inc.  Topix3 weeks ago NOVARTIS : Mississippi SC upholds a multi-million dollar verdict in opposition to Sandoz, Inc.  4 Traders3 weeks ago

Amgen Seeks FDA Approval for First Biosimilar of Humira

Amgen Inc. AMGN announced the submission of a biologics license application (BLA) seeking FDA approval for ABP 501, a biosimilar version of AbbVie Inc.'s ABBV best-selling drug, Humira. The application is Amgen's first BLA submitted under the 351(k) ...
 Yahoo! Finance1 day ago

4 Reasons This Pharma Mega-Merger Could Be Terrible For You

All eyes are on Pfizer Inc. and Allergan PLC this week following the pharmaceutical giants' Monday announcement that they plan to undertake a mega-merger .Not everyone likes what they're seeing. Pfizer said it will buy Allergan for$160 billion, ...
 Huffington Post4 days ago

11.23.15 -- What Questions Remain After Amgen vs. Sandoz?

Over the past 30 years a number of biologics have been commercially licensed that are produced by continuous bioprocessing for some portion of the production line. Today, continuous bioprocessing is being considered by more firms for ...
 Bioresearch Online5 days ago
Jutia Group

FDA to Consider Competitor for Amgen's Neulasta

The Food and Drug Administration on Wednesday accepted paperwork for approval of a biosimilar version of Amgen Inc.'s Neulasta, a drug that produces white blood cells to fight infection in cancer patients. Last month, the Thousand Oaks ...
 San Fernando Valley Business Journal1 week ago Here's How Novartis AG Neulasta Biosimilar Would Impact Amgen, Inc  Bidness Etc1 week ago Market Update (NASDAQ:AMGN): Novartis biosimilar copycat takes aim at Amgen's drug Enbrel  Jutia Group1 month ago Novartis biosimilar copycat takes aim at Amgen's drug Enbrel  4 Traders1 month ago

Novartis: FDA Accepts BLA for Biosimilar Version of Neulasta

Novartis NVS announced the acceptance of its generic arm Sandoz Biologics License Application (BLA) for its proposed biosimilar of Amgen's AMGN Neulasta by the FDA. The BLA was accepted under the 351 (k) pathway. We note that Neulasta helps ...
 Zacks.com1 week ago FDA Accepts Sandoz' Regulatory Submission For Proposed Biosimilar Pegfilgrastim  Nasdaq1 week ago Regulatory submission for Sandoz' proposed biosimilar pegfilgrastim accepted by the FDA  Bloomberg1 week ago GNW-News: Regulatory submission for Sandoz' proposed biosimilar pegfilgrastim accepted by the FDA (english)  Pharmacy Choice1 week ago
Business Insider

Facebook activates 'Safety Check' for Nigeria blasts after criticism

A Facebook logo is displayed on the side of a tour bus in New York's financial district (Reuters) - Facebook Inc activated its "Safety Check" feature after deadly blasts in Nigeria late on Tuesday following criticism from users that the social ...
 Business Insider1 week ago

IMNP: Clinical Sites to Open for BP Trial in the U.S.…

By David Bautz, PhD NASDAQ:IMNP Financial Update On November 11, 2015, Immune Pharmaceuticals, Inc. ( IMNP ) announced financial results for the third quarter of 2015 and provided a business update. The company did not report any revenue ...
 Yahoo! Finance1 week ago

Anacor Pharmaceuticals Reports Third Quarter 2015 Financial Results

Recognized $21.1 million in total KERYDIN revenue in the third quarter of 2015 under the Sandoz Agreement, representing a sequential increase of 18.8% over the second quarter of 2015 Top-line results from the long-term safety study of crisaborole ...
 Bloomberg3 weeks ago Anacor Pharmaceuticals to Report Third Quarter 2015 Financial Results on November 3, 2015  Individual.com1 month ago Anacor Pharmaceuticals Announces Presentations Of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data At Two Upcoming Medical Conferences  TheStreet.com2 months ago Anacor Pharmaceuticals to Present at the Jefferies Autumn 2015 Global Healthcare Conference  Pharmacy Choice2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less